Biologic therapies are better suited for advanced degeneration, chronic pain from structural issues, long-term joint deterioration, and significant tendon or ligament injury
Wegovy (semaglutide) and Mounjaro (tirzepatide) are the two leading prescription GLP-1 medications available to Irish patients in 2026, and the question of which to choose is one of the most common we hear at Bua Health
The specific timeline depends on individual tolerance, genetic factors assessed through PlexusDx's Precision Peptide Genetic Test, and whether patients are escalating semaglutide injection or oral formulations
Modern small-molecule and biologic drug development is built on defined molecular targets
Patients balancing work, family, and health appreciate this flexibility
Endocrinology (2013) 154:355264